Penumbra, Inc. (PEN) Social Stream
PENUMBRA INC (PEN) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering PEN.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 6 | $350 | $204 | $303.666 | $239.51 | 26.79% |
| 2021-11-05 | 7 | $350 | $204 | $302.428 | $239.51 | 26.27% |
| 2022-02-17 | 6 | $350 | $308 | $323.6 | $239.51 | 35.11% |
| 2022-02-23 | 4 | $308 | $300 | $302.666 | $239.51 | 26.37% |
| 2022-04-29 | 5 | $308 | $250 | $289.5 | $239.51 | 20.87% |
| 2022-05-04 | 6 | $308 | $250 | $289.5 | $239.51 | 20.87% |
| 2022-05-05 | 6 | $308 | $240 | $261.6 | $239.51 | 9.22% |
| 2022-05-17 | 6 | $308 | $220 | $254.666 | $239.51 | 6.33% |
| 2022-08-05 | 7 | $265 | $163 | $211.571 | $239.51 | -11.67% |
| 2022-08-08 | 7 | $265 | $163 | $200 | $239.51 | -16.5% |
| 2022-09-13 | 8 | $265 | $163 | $210.444 | $239.51 | -12.14% |
| 2022-09-19 | 8 | $265 | $163 | $213.333 | $239.51 | -10.93% |
| 2022-10-05 | 9 | $265 | $163 | $213 | $239.51 | -11.07% |
| 2022-10-12 | 10 | $265 | $163 | $214.7 | $239.51 | -10.36% |
| 2022-10-28 | 10 | $265 | $175 | $218.6 | $239.51 | -8.73% |
| 2022-10-31 | 10 | $265 | $189 | $223.1 | $239.51 | -6.85% |
| 2022-11-04 | 10 | $265 | $189 | $223.1 | $239.51 | -6.85% |
| 2022-11-07 | 11 | $265 | $189 | $212.6 | $239.51 | -11.24% |
| 2022-11-14 | 11 | $235 | $167 | $206.8 | $239.51 | -13.66% |
| 2022-12-05 | 11 | $240 | $167 | $210.4 | $239.51 | -12.15% |
| 2022-12-12 | 11 | $270 | $167 | $219.2 | $239.51 | -8.48% |
| 2022-12-13 | 11 | $270 | $185 | $227.9 | $239.51 | -4.85% |
| 2023-01-03 | 11 | $270 | $185 | $230.6 | $239.51 | -3.72% |
| 2023-01-05 | 11 | $270 | $185 | $235.4 | $239.51 | -1.72% |
The Trend in the Analyst Price Target
PEN's average price target has moved up $22.4 over the prior 92 days.
Over the past 46 weeks, PEN's average upside potential has been 29.1%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-08-05 | 7 | 265 | 163 | 211.571 | 166.83 | 26.82% |
| 2022-09-19 | 9 | 265 | 163 | 213.333 | 194.45 | 9.71% |
| 2022-10-05 | 9 | 265 | 163 | 213.000 | 196.23 | 8.55% |
| 2022-11-07 | 11 | 235 | 167 | 202.000 | 178.16 | 13.38% |
| 2022-12-05 | 11 | 240 | 167 | 210.400 | 212.00 | -0.75% |
PEN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.18 | 9 | 2 | 0 | 0 | 0 | 11 |
The Trend in the Broker Recommendations
PEN's average broker recommendation rating worsened by 0.18 over the prior 32 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, PENUMBRA INC's average analyst price target is higher than 2934.55% of them.
- In the context of Healthcare stocks, PENUMBRA INC's upside potential (average analyst target price relative to current price) is greater than 366.13% of them.
- PEN has a higher number of analysts covering the stock than 705.43% of stocks in the large market cap category.
- In terms of how PENUMBRA INC fares relative to Healthcare stocks, note that its variance in analysts' estimates is lower than -870.8% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Medical Equipment industry with the ratings most similar to PENUMBRA INC are NVCR, PODD, and DXCM.
View All Top Stocks by Price Target
What is the outlook for PEN? Use POWR Ratings for clearer insight into price direction.